I. Nyoman Hariyasa Sanjaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
I. Nyoman Hariyasa Sanjaya has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Dudy Aldiansyah
Department of Obstetrics and Gynecology, Fetomaternal Division, Faculty of Medicine, Sumatera Utara University, H. Adam Malik General Hospital, Medan, North Sumatera, Indonesia
5 shared publications - Julian Dewantiningrum
Department of Obstetrics and Gynecology, Fetomaternal Division, Medical Faculty of Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia
5 shared publications - Mochammad Besari Adi Pramono
Department of Obstetrics and Gynecology, Fetomaternal Division, Medical Faculty of Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia
5 shared publications - Muhammad Adrianes Bachnas
Fetomaternal Division, Department of Obstetrics and Gynecology , Medical Faculty of Sebelas Maret University, Dr. Moewardi Hospital , Surakarta , Indonesia
5 shared publications - Wiku Andonotopo
Department of Obstetrics and Gynecology, Fetomaternal Division, Faculty of Medicine, Maranatha Christian University, Maranatha Hospital, Bandung, West Java, Indonesia
5 shared publications - Aloysius Suryawan
Department of Obstetrics and Gynecology, Fetomaternal Division, Faculty of Medicine, Maranatha Christian University, Maranatha Hospital, Bandung, West Java, Indonesia
3 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Wolters Kluwer Health in West Kazakhstan Medical Journal
- Vol. 68 (4) , 339-361
The Hidden Fetal Genome after Negative Exome Sequencing: Incremental Diagnostic and Clinical Utility of Short-read and Long-read Genome Sequencing in Fetuses with Structural Anomalies – A Systematic Review
A BSTRACT: Despite major advances in prenatal exome sequencing (ES), many fetuses with structural anomalies still do not receive a molecular diagnosis. Growing evidence suggests that these unresolved cases may contain pathogenic variants within the “hidden fetal genome,” including complex structural rearrangements, repeat expansions, deep intronic and regulatory variants, balanced chromosomal abnormalities, mobile element insertions, and other genomic changes that conventional ES often misses. This systematic review examined the additional diagnostic and clinical value of short read and long read whole genome sequencing (WGS) after nondiagnostic prenatal ES in fetuses with structural anomalies. A systematic literature search was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Eligible publications included original research, systematic reviews, and implementation studies assessing prenatal genome sequencing after standard cytogenetic and exome-based testing. Twenty-nine studies met the predefined eligibility criteria and were included in the qualitative synthesis. Overall, the evidence shows that short read WGS expands genomic analysis beyond coding regions and improves detection of pathogenic copy number variants, noncoding variants, and selected structural alterations. Long read sequencing provides further advantages by identifying complex genomic architecture, repeat expansions, balanced rearrangements, phased alleles, and difficult-to-map genomic regions that often remain undetected with short read methods. In addition to increasing diagnostic yield, genome sequencing supports prenatal counseling, pregnancy management, delivery planning, neonatal care, and recurrence risk assessment, demonstrating its growing importance in maternal fetal medicine. However, challenges involving variant interpretation, limited prenatal phenotyping, cost, infrastructure, and equitable access continue to limit broader clinical adoption. Across the included studies, incremental diagnostic yield varied according to fetal phenotype and sequencing strategy but consistently favored genome sequencing over ES for selected unresolved cases. Combining complementary genome sequencing approaches within multidisciplinary prenatal diagnostic pathways may reduce the hidden fetal genome and strengthen precision prenatal genomics, although prospective multicenter studies remain necessary to establish the most effective strategies for clinical implementation.
- 1 September 2026
- Published by Wolters Kluwer Health in West Kazakhstan Medical Journal
- Vol. 68 (4) , 339-361
Open AccessThe Hidden Fetal Genome after Negative Exome Sequencing: Incremental Diagnostic and Clinical Utility of Short-read and Long-read Genome Sequencing in Fetuses with Structural Anomalies – A Systematic Review
A BSTRACT: Despite major advances in prenatal exome sequencing (ES), many fetuses with structural anomalies still do not receive a molecular diagnosis. Growing evidence suggests that these unresolved cases may contain pathogenic variants within the “hidden fetal genome,” including complex structural rearrangements, repeat expansions, deep intronic and regulatory variants, balanced chromosomal abnormalities, mobile element insertions, and other genomic changes that conventional ES often misses. This systematic review examined the additional diagnostic and clinical value of short read and long read whole genome sequencing (WGS) after nondiagnostic prenatal ES in fetuses with structural anomalies. A systematic literature search was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Eligible publications included original research, systematic reviews, and implementation studies assessing prenatal genome sequencing after standard cytogenetic and exome-based testing. Twenty-nine studies met the predefined eligibility criteria and were included in the qualitative synthesis. Overall, the evidence shows that short read WGS expands genomic analysis beyond coding regions and improves detection of pathogenic copy number variants, noncoding variants, and selected structural alterations. Long read sequencing provides further advantages by identifying complex genomic architecture, repeat expansions, balanced rearrangements, phased alleles, and difficult-to-map genomic regions that often remain undetected with short read methods. In addition to increasing diagnostic yield, genome sequencing supports prenatal counseling, pregnancy management, delivery planning, neonatal care, and recurrence risk assessment, demonstrating its growing importance in maternal fetal medicine. However, challenges involving variant interpretation, limited prenatal phenotyping, cost, infrastructure, and equitable access continue to limit broader clinical adoption. Across the included studies, incremental diagnostic yield varied according to fetal phenotype and sequencing strategy but consistently favored genome sequencing over ES for selected unresolved cases. Combining complementary genome sequencing approaches within multidisciplinary prenatal diagnostic pathways may reduce the hidden fetal genome and strengthen precision prenatal genomics, although prospective multicenter studies remain necessary to establish the most effective strategies for clinical implementation.
- Open Access
- 1 July 2026
- Published by Wolters Kluwer Health in West Kazakhstan Public Health Journal
- Vol. 14 (3) , 193-215
Commercial Air Travel During Pregnancy: A Journey-based Systematic Review of Airport Security Screening, Cabin Environmental Exposure, Turbulence, Venous Thromboembolism, and Evidence-based Maternal–Fetal Safety Recommendations
A BSTRACT: Commercial air travel during pregnancy has become increasingly common, yet uncertainty regarding maternal–fetal safety persists among pregnant travelers and healthcare professionals. Existing reviews have generally examined individual issues, such as venous thromboembolism, cabin hypoxia, or radiation exposure, without integrating the sequence of exposures encountered throughout the travel journey. This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses 2020 Statement to synthesize the available evidence from a journey-based clinical perspective, spanning airport security screening, aircraft cabin environmental conditions, prolonged immobility, turbulence, venous thromboembolism, and maternal–fetal outcomes. Electronic databases were systematically searched, and 33 eligible publications were included in a qualitative synthesis comprising observational studies, physiological investigations, epidemiological studies, narrative reviews, professional guidelines, and selected case reports. Routine airport security screening and occasional exposure to cosmic radiation during commercial flights were consistently associated with negligible fetal risk in uncomplicated pregnancies. Available evidence also indicated that healthy pregnant women generally tolerate mild cabin hypobaric hypoxia and reduced humidity through normal physiological adaptation, whereas those with significant cardiopulmonary disease, severe anemia, or high-risk obstetric conditions require individualized pretravel assessment. Across the reviewed literature, the strongest and most consistent evidence concerned the interaction between pregnancy-related hypercoagulability and prolonged immobility, supporting preventive strategies including hydration, periodic ambulation, and graduated compression stockings for appropriately selected women. Evidence linking turbulence to adverse obstetric outcomes remained limited and was derived largely from isolated case reports, emphasizing correct seat-belt use rather than routine travel restriction. Rather than introducing new biological evidence, this review proposes a journey-based framework that integrates previously fragmented literature into a clinically applicable approach for risk stratification and counseling. As a preliminary evidence synthesis intended to consolidate current knowledge and identify research gaps, the findings suggest that commercial air travel is generally well tolerated in uncomplicated pregnancies, although conclusions should be interpreted in light of the predominantly observational nature of the available evidence and the need for further prospective investigation.
- 1 July 2026
- Published by Wolters Kluwer Health in West Kazakhstan Public Health Journal
- Vol. 14 (3) , 193-215
Open AccessCommercial Air Travel During Pregnancy: A Journey-based Systematic Review of Airport Security Screening, Cabin Environmental Exposure, Turbulence, Venous Thromboembolism, and Evidence-based Maternal–Fetal Safety Recommendations
A BSTRACT: Commercial air travel during pregnancy has become increasingly common, yet uncertainty regarding maternal–fetal safety persists among pregnant travelers and healthcare professionals. Existing reviews have generally examined individual issues, such as venous thromboembolism, cabin hypoxia, or radiation exposure, without integrating the sequence of exposures encountered throughout the travel journey. This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses 2020 Statement to synthesize the available evidence from a journey-based clinical perspective, spanning airport security screening, aircraft cabin environmental conditions, prolonged immobility, turbulence, venous thromboembolism, and maternal–fetal outcomes. Electronic databases were systematically searched, and 33 eligible publications were included in a qualitative synthesis comprising observational studies, physiological investigations, epidemiological studies, narrative reviews, professional guidelines, and selected case reports. Routine airport security screening and occasional exposure to cosmic radiation during commercial flights were consistently associated with negligible fetal risk in uncomplicated pregnancies. Available evidence also indicated that healthy pregnant women generally tolerate mild cabin hypobaric hypoxia and reduced humidity through normal physiological adaptation, whereas those with significant cardiopulmonary disease, severe anemia, or high-risk obstetric conditions require individualized pretravel assessment. Across the reviewed literature, the strongest and most consistent evidence concerned the interaction between pregnancy-related hypercoagulability and prolonged immobility, supporting preventive strategies including hydration, periodic ambulation, and graduated compression stockings for appropriately selected women. Evidence linking turbulence to adverse obstetric outcomes remained limited and was derived largely from isolated case reports, emphasizing correct seat-belt use rather than routine travel restriction. Rather than introducing new biological evidence, this review proposes a journey-based framework that integrates previously fragmented literature into a clinically applicable approach for risk stratification and counseling. As a preliminary evidence synthesis intended to consolidate current knowledge and identify research gaps, the findings suggest that commercial air travel is generally well tolerated in uncomplicated pregnancies, although conclusions should be interpreted in light of the predominantly observational nature of the available evidence and the need for further prospective investigation.
- Open Access
- 1 July 2026
- Published by Wolters Kluwer Health in West Kazakhstan Public Health Journal
- Vol. 14 (3) , 177-192
Artificial Intelligence in Scientific Manuscript Preparation in Medical Science: A Scoping Review of Applications, Ethical Considerations, and Emerging Practices
A BSTRACT: Artificial intelligence (AI) has rapidly entered scientific publishing workflows, including biomedical manuscript preparation. In Medical Science , where published evidence may directly influence clinical decision-making for both mother and fetus, the implications of AI-assisted writing warrant careful scrutiny. Although AI tools can support literature exploration, drafting, and language refinement, concerns persist regarding fabricated references, incomplete disclosure, and potential shifts in authorship responsibility. Existing evidence remains heterogeneous and dispersed across empirical and nonempirical sources. This study was conducted as a scoping review guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 recommendations to map the range and characteristics of the available literature. Searches of PubMed/MEDLINE, Embase, Scopus, Web of Science, the Cochrane Library, and PubMed Central identified relevant studies. Following screening of 850 records, 43 studies were included in a qualitative synthesis. Given the diversity of study designs, a structured qualitative methodological appraisal was applied rather than formal risk-of-bias tools. AI applications were most frequently reported in literature discovery, drafting support, and language editing. However, recurrent concerns included hallucinated citations, variable accuracy, and inconsistent transparency in AI use. AI may enhance efficiency in manuscript preparation, but current evidence, largely nonempirical, remains limited. Findings should be interpreted cautiously and are intended to inform, rather than prescribe, responsible integration of AI in medical scientific writing.
- 1 July 2026
- Published by Wolters Kluwer Health in West Kazakhstan Public Health Journal
- Vol. 14 (3) , 177-192
Open AccessArtificial Intelligence in Scientific Manuscript Preparation in Medical Science: A Scoping Review of Applications, Ethical Considerations, and Emerging Practices
A BSTRACT: Artificial intelligence (AI) has rapidly entered scientific publishing workflows, including biomedical manuscript preparation. In Medical Science , where published evidence may directly influence clinical decision-making for both mother and fetus, the implications of AI-assisted writing warrant careful scrutiny. Although AI tools can support literature exploration, drafting, and language refinement, concerns persist regarding fabricated references, incomplete disclosure, and potential shifts in authorship responsibility. Existing evidence remains heterogeneous and dispersed across empirical and nonempirical sources. This study was conducted as a scoping review guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 recommendations to map the range and characteristics of the available literature. Searches of PubMed/MEDLINE, Embase, Scopus, Web of Science, the Cochrane Library, and PubMed Central identified relevant studies. Following screening of 850 records, 43 studies were included in a qualitative synthesis. Given the diversity of study designs, a structured qualitative methodological appraisal was applied rather than formal risk-of-bias tools. AI applications were most frequently reported in literature discovery, drafting support, and language editing. However, recurrent concerns included hallucinated citations, variable accuracy, and inconsistent transparency in AI use. AI may enhance efficiency in manuscript preparation, but current evidence, largely nonempirical, remains limited. Findings should be interpreted cautiously and are intended to inform, rather than prescribe, responsible integration of AI in medical scientific writing.
- Open Access
- 3 May 2026
- Published by Universitas Airlangga in Majalah Obstetri & Ginekologi
- Vol. 34 (1)
Limb-Body Wall Complex: A rare case report and systematic review
HIGHLIGHTS Evolution from suspected gastroschisis (17+1 weeks) to confirmed LBWC at 20 weeks with classic features (thoracoabdominal wall defect, intestinal malrotation, limb anomalies), aligned with a systematic review of 23 studies (155 cases) showing mainly second-trimester ultrasound diagnosis and uniformly poor prognosis. Early diagnostic pathways (2D/3D ultrasound ± Doppler; adjunct MRI/AFP/genetics) sharpen differentiation from gastroschisis/omphalocele and strengthen evidence for prenatal counseling, management (including termination and delivery planning), and postmortem confirmation. ABSTRACT Objective: To report a rare case of Limb-Body Wall Complex (LBWC) and to synthesize current evidence regarding its diagnostic features, clinical presentation, and outcomes through a structured literature review. Case Report: This study integrates a single case report with a structured review of published cases. A 29-year-old gravida 2 para 0 woman at 20 weeks of gestation presented with absent fetal movement and was diagnosed with intrauterine fetal death accompanied by multiple congenital anomalies. Initial antenatal ultrasound at 17 weeks and 1 day suggested gastroschisis; however, subsequent evaluation confirmed LBWC, characterized by thoracoabdominal wall defect, intestinal malrotation, and limb anomalies. Pregnancy termination was performed using misoprostol, and the fetus was delivered vaginally as a stillbirth. Diagnosis was confirmed macroscopically post-delivery. The literature review, conducted in accordance with PRISMA 2020 guidelines using PEOS criteria, identified 23 eligible studies comprising 155 cases. Most diagnoses were established in the first and second trimesters using ultrasound, with adjunctive imaging or genetic testing in selected cases. Across studies, LBWC consistently demonstrated a uniformly poor prognosis, with outcomes including intrauterine fetal demise, termination of pregnancy, or early neonatal death. Common findings included limb agenesis, scoliosis, short or absent umbilical cord, and organ evisceration. Most included studies were of moderate to high methodological quality. Conclusion: LBWC is a rare and lethal congenital anomaly. Early and accurate antenatal diagnosis, particularly through repeated ultrasound evaluation, is essential to guide clinical decision-making, parental counseling, and pregnancy management
- 3 May 2026
- Published by Universitas Airlangga in Majalah Obstetri & Ginekologi
- Vol. 34 (1)
Open AccessLimb-Body Wall Complex: A rare case report and systematic review
HIGHLIGHTS Evolution from suspected gastroschisis (17+1 weeks) to confirmed LBWC at 20 weeks with classic features (thoracoabdominal wall defect, intestinal malrotation, limb anomalies), aligned with a systematic review of 23 studies (155 cases) showing mainly second-trimester ultrasound diagnosis and uniformly poor prognosis. Early diagnostic pathways (2D/3D ultrasound ± Doppler; adjunct MRI/AFP/genetics) sharpen differentiation from gastroschisis/omphalocele and strengthen evidence for prenatal counseling, management (including termination and delivery planning), and postmortem confirmation. ABSTRACT Objective: To report a rare case of Limb-Body Wall Complex (LBWC) and to synthesize current evidence regarding its diagnostic features, clinical presentation, and outcomes through a structured literature review. Case Report: This study integrates a single case report with a structured review of published cases. A 29-year-old gravida 2 para 0 woman at 20 weeks of gestation presented with absent fetal movement and was diagnosed with intrauterine fetal death accompanied by multiple congenital anomalies. Initial antenatal ultrasound at 17 weeks and 1 day suggested gastroschisis; however, subsequent evaluation confirmed LBWC, characterized by thoracoabdominal wall defect, intestinal malrotation, and limb anomalies. Pregnancy termination was performed using misoprostol, and the fetus was delivered vaginally as a stillbirth. Diagnosis was confirmed macroscopically post-delivery. The literature review, conducted in accordance with PRISMA 2020 guidelines using PEOS criteria, identified 23 eligible studies comprising 155 cases. Most diagnoses were established in the first and second trimesters using ultrasound, with adjunctive imaging or genetic testing in selected cases. Across studies, LBWC consistently demonstrated a uniformly poor prognosis, with outcomes including intrauterine fetal demise, termination of pregnancy, or early neonatal death. Common findings included limb agenesis, scoliosis, short or absent umbilical cord, and organ evisceration. Most included studies were of moderate to high methodological quality. Conclusion: LBWC is a rare and lethal congenital anomaly. Early and accurate antenatal diagnosis, particularly through repeated ultrasound evaluation, is essential to guide clinical decision-making, parental counseling, and pregnancy management
- Open Access
- 3 May 2026
- Published by Universitas Airlangga in Majalah Obstetri & Ginekologi
- Vol. 34 (1)
Placental micro- and nanoplastic contamination: A systematic review of eco-exposome pathways to preterm birth and neonatal outcomes
HIGHLIGHTS First comprehensive synthesis of human and mechanistic evidence linking placental micro- and nanoplastic (MNP) contamination to preterm birth and neonatal outcomes. Quantitative human studies demonstrate higher placental MNP burdens in preterm versus term pregnancies. Molecular pathways identified include oxidative stress, ferroptosis-driven syncytiotrophoblast senescence, trophoblast invasion impairment, inflammatory signaling, endocrine disruption, and epigenetic modifications. Clinical and policy relevance: Findings support the need for standardized biomonitoring, maternal exposure mitigation, and the integration of eco-exposome considerations into perinatal care. ABSTRACT Objective: To systematically review emerging evidence on micro- and nanoplastic (MNP) contamination of the human placenta, explore molecular pathways underlying placental dysfunction, and evaluate associations with preterm birth and neonatal outcomes. Materials and Methods: Following PRISMA 2020 guidelines, literature searches (in PubMed, Web of Science, and Scopus) and grey sources were conducted through July 2025. Inclusion criteria comprised studies detecting MNPs in the human placenta or fetal compartments, mechanistic experiments using human placental models, or reviews addressing pregnancy outcomes. Methodological quality was assessed using AMSTAR-2, ROBIS, or the Newcastle–Ottawa Scale. Data were synthesized into three evidence domains: human biomonitoring, molecular pathways, and clinical implications. Results: Twenty studies met the inclusion criteria. MNPs were consistently detected in the human placenta, amniotic fluid, cord blood, and meconium, with higher burdens in preterm versus term placentae. Mechanistic studies demonstrated oxidative stress, ferroptosis-mediated syncytiotrophoblast senescence, impaired trophoblast invasion, inflammatory responses (IL-6, TNF-a, NLRP3 activation), endocrine disruption (altered ß-hCG and progesterone signaling), and epigenetic modifications. These pathways converge to impair nutrient and oxygen exchange and immune tolerance, increasing the risks of preterm birth, fetal growth restriction, low birth weight, and neonatal respiratory and metabolic vulnerability. Conclusion: Micro- and nanoplastic contamination of the human placenta is increasingly documented and biologically plausible as a contributor to preterm birth and neonatal morbidity. These findings support urgent investigation of exposure mitigation, standardized biomonitoring, and the integration of eco-exposome risks into perinatal clinical practice and policy.
- 3 May 2026
- Published by Universitas Airlangga in Majalah Obstetri & Ginekologi
- Vol. 34 (1)
Open AccessPlacental micro- and nanoplastic contamination: A systematic review of eco-exposome pathways to preterm birth and neonatal outcomes
HIGHLIGHTS First comprehensive synthesis of human and mechanistic evidence linking placental micro- and nanoplastic (MNP) contamination to preterm birth and neonatal outcomes. Quantitative human studies demonstrate higher placental MNP burdens in preterm versus term pregnancies. Molecular pathways identified include oxidative stress, ferroptosis-driven syncytiotrophoblast senescence, trophoblast invasion impairment, inflammatory signaling, endocrine disruption, and epigenetic modifications. Clinical and policy relevance: Findings support the need for standardized biomonitoring, maternal exposure mitigation, and the integration of eco-exposome considerations into perinatal care. ABSTRACT Objective: To systematically review emerging evidence on micro- and nanoplastic (MNP) contamination of the human placenta, explore molecular pathways underlying placental dysfunction, and evaluate associations with preterm birth and neonatal outcomes. Materials and Methods: Following PRISMA 2020 guidelines, literature searches (in PubMed, Web of Science, and Scopus) and grey sources were conducted through July 2025. Inclusion criteria comprised studies detecting MNPs in the human placenta or fetal compartments, mechanistic experiments using human placental models, or reviews addressing pregnancy outcomes. Methodological quality was assessed using AMSTAR-2, ROBIS, or the Newcastle–Ottawa Scale. Data were synthesized into three evidence domains: human biomonitoring, molecular pathways, and clinical implications. Results: Twenty studies met the inclusion criteria. MNPs were consistently detected in the human placenta, amniotic fluid, cord blood, and meconium, with higher burdens in preterm versus term placentae. Mechanistic studies demonstrated oxidative stress, ferroptosis-mediated syncytiotrophoblast senescence, impaired trophoblast invasion, inflammatory responses (IL-6, TNF-a, NLRP3 activation), endocrine disruption (altered ß-hCG and progesterone signaling), and epigenetic modifications. These pathways converge to impair nutrient and oxygen exchange and immune tolerance, increasing the risks of preterm birth, fetal growth restriction, low birth weight, and neonatal respiratory and metabolic vulnerability. Conclusion: Micro- and nanoplastic contamination of the human placenta is increasingly documented and biologically plausible as a contributor to preterm birth and neonatal morbidity. These findings support urgent investigation of exposure mitigation, standardized biomonitoring, and the integration of eco-exposome risks into perinatal clinical practice and policy.
- Open Access
- 26 November 2025
- Published by Universitas Airlangga in Majalah Obstetri & Ginekologi
- Vol. 33 (3) , 236-248
Perinatal exposure to ultraprocessed foods and its impact on maternal gut dysbiosis, placental inflammation, and neonatal immune programming: A systematic review
HIGHLIGHTS ABSTRACT Objective: To synthesize and critically evaluate evidence linking perinatal exposure to ultraprocessed foods (UPFs) with maternal gut dysbiosis, placental inflammation, and neonatal immune programming, and to identify translational implications for perinatal care. Materials and Methods: A systematic narrative review was conducted following PRISMA 2020 guidelines, without PROSPERO registration. Literature searches of major databases (2000–March 2025) identified 1,845 records. After screening and eligibility assessment, 20 studies were included. Study quality was appraised using validated tools, and data were synthesized thematically into evidence domains covering maternal microbiota, inflammatory pathways, placental changes, and neonatal immune outcomes. Results: Maternal UPF consumption was associated with gut dysbiosis characterized by reduced microbial diversity, increased pro-inflammatory taxa, and systemic endotoxemia. Elevated inflammatory biomarkers including lipopolysaccharide, interleukin‑6, tumor necrosis factor‑a, and C‑reactive protein were frequently reported. Limited placental studies revealed increased innate immune activation and oxidative stress. Neonatal immune alterations included regulatory T cell suppression, T helper 2 skewing, increased allergic sensitization, and metabolic programming changes. Evidence strength was highest for maternal gut dysbiosis and immune programming but limited for direct placental mechanisms. Translational opportunities include dietary counseling, microbiota-targeted interventions, and public health strategies aimed at improving maternal diet quality. Conclusion: Perinatal exposure to UPFs adversely impacts the maternal gut–placenta–fetal immune axis. Integrated dietary interventions and population-level nutrition policies are urgently needed to mitigate downstream transgenerational immune risk.
- 26 November 2025
- Published by Universitas Airlangga in Majalah Obstetri & Ginekologi
- Vol. 33 (3) , 236-248
Open AccessPerinatal exposure to ultraprocessed foods and its impact on maternal gut dysbiosis, placental inflammation, and neonatal immune programming: A systematic review
HIGHLIGHTS ABSTRACT Objective: To synthesize and critically evaluate evidence linking perinatal exposure to ultraprocessed foods (UPFs) with maternal gut dysbiosis, placental inflammation, and neonatal immune programming, and to identify translational implications for perinatal care. Materials and Methods: A systematic narrative review was conducted following PRISMA 2020 guidelines, without PROSPERO registration. Literature searches of major databases (2000–March 2025) identified 1,845 records. After screening and eligibility assessment, 20 studies were included. Study quality was appraised using validated tools, and data were synthesized thematically into evidence domains covering maternal microbiota, inflammatory pathways, placental changes, and neonatal immune outcomes. Results: Maternal UPF consumption was associated with gut dysbiosis characterized by reduced microbial diversity, increased pro-inflammatory taxa, and systemic endotoxemia. Elevated inflammatory biomarkers including lipopolysaccharide, interleukin‑6, tumor necrosis factor‑a, and C‑reactive protein were frequently reported. Limited placental studies revealed increased innate immune activation and oxidative stress. Neonatal immune alterations included regulatory T cell suppression, T helper 2 skewing, increased allergic sensitization, and metabolic programming changes. Evidence strength was highest for maternal gut dysbiosis and immune programming but limited for direct placental mechanisms. Translational opportunities include dietary counseling, microbiota-targeted interventions, and public health strategies aimed at improving maternal diet quality. Conclusion: Perinatal exposure to UPFs adversely impacts the maternal gut–placenta–fetal immune axis. Integrated dietary interventions and population-level nutrition policies are urgently needed to mitigate downstream transgenerational immune risk.